Please scroll down for Indications and Important Safety Information.
Clearly labeled caps, a red injector tip, and explicit instructions are all standard features with Adrenaclick®—a single-dose epinephrine auto-injector that is designed for ease of use and accuracy
Learn how to use Adrenaclick®.
Adrenaclick® (epinephrine injection, USP) is indicated in the emergency treatment of severe allergic reactions (Type I) including anaphylaxis to stinging insects (e.g., order Hymenoptera, which includes bees, wasps, hornets, yellow jackets and fire ants), and biting insects (e.g., triatoma, mosquitos), allergen immunotherapy, foods, drugs, diagnostic testing substances (e.g., radiocontrast media), and other allergens, as well as anaphylaxis to unknown substances (idiopathic anaphylaxis) or exercise-induced anaphylaxis.
Adrenaclick® is intended for immediate administration in patients with a history of anaphylactic reactions. Selection of the appropriate dosage strength is determined according to patient body weight. Such reactions may occur within minutes after exposure and consist of flushing, apprehension, syncope, tachycardia, thready or unobtainable pulse associated with a fall in blood pressure, convulsions, vomiting, diarrhea and abdominal cramps, involuntary voiding, wheezing, dyspnea due to laryngeal spasm, pruritus, rashes, urticaria, or angioedema.
Adrenaclick® should only be injected into the anterolateral aspect of the thigh. Accidental injection into the hands or feet may result in loss of blood flow to the affected area and should be avoided. DO NOT INJECT INTO BUTTOCK. DO NOT INJECT INTRAVENOUSLY.
Epinephrine should be administered with caution to patients with cardiac arrhythmias, coronary artery or organic heart disease, or hypertension. In patients with coronary insufficiency or ischemic heart disease, epinephrine may precipitate or aggravate angina pectoris as well as produce ventricular arrhythmias. It should be recognized that the presence of these conditions is not a contraindication to epinephrine administration in an acute, life-threatening situation.
Adverse reactions to epinephrine include transient, moderate anxiety; apprehensiveness; restlessness; tremor; weakness; dizziness; sweating; palpitations; pallor; nausea and vomiting; headache, and/or respiratory difficulties.
The effects of epinephrine may be potentiated by tricyclic antidepressants, monoamine oxidase inhibitors, sodium levothyroxine, and certain antihistamines, notably chlorpheniramine, tripelennamine, and diphenhydramine.
Adrenaclick® is designed as an emergency supportive therapy only and is not a replacement or substitute for immediate medical care.
Since the dose of epinephrine delivered from Adrenaclick® is fixed, the physician should consider other forms of injectable epinephrine if doses lower than those available from Adrenaclick® are felt to be necessary (e.g., patients who weigh less than 15 kilograms, approximately 33 pounds).
IN ALL CASES, THE PHYSICIAN SHOULD INSTRUCT THE PATIENT AND/OR ANY OTHER PERSON WHO MIGHT BE IN A POSITION TO ADMINISTER THE EPINEPHRINE, IN THE PROPER USE OF Adrenaclick®.
Click here for full Prescribing Information for Adrenaclick®
Adrenaclick™ is a trademark of Shionogi Inc.
© 2011 Shionogi Inc. Florham Park, NJ. All rights reserved. ADR.11.09.069.03
This Website and its contents are intended for use only by residents of the United States. Products discussed may have different label regulatory requirements, and/or medical practices in other countries that may require reference to different or additional information.
|